Interested in doing a bit of “light reading” this weekend? Then don’t access the following three links I have been saving since November!
Maybe you should just file these away for anytime you need a detailed anti-myeloma drug profile:
The Future of Treatment for Patients With Relapsed/R
efractory Multiple Myeloma
Lots of in-depth information here about new proteasome inhibitors in the pipeline:
Current Advances in Novel Proteasome Inhibitor–Based Approaches to the Treatment of Relapsed/Refractory Multiple Myeloma
CLICK-HERE to access.
Current Advances in Non–Proteasome Inhibitor–Based Approaches to the Treatment of Relapsed/Refractory Multiple Myeloma
CLICK-HERE to read all about thalidomide, Revlimid, pomalidomide and a number of other new novel therapy agents in the pipeline.
Finally, what does ingesting all of these chemotherapy agents do to our bodies? What are the risks?
Treatment-Related Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma
CLICK-HERE to read Washington University’s Dr. Raj systematically lay-out the possible side-effects associated with myeloma therapy.
This is an excellent series, sponsored by Cancer Network. Well worth a look.
But enough about drugs and drug therapy. Monday, our friend Danny will share more thoughts about how to help combat multiple myeloma by using sound nutrition, targeted supplementation and a healthy lifestyle.
Until then, feel good and keep smiling! Pat